vs
FLOWERS FOODS INC（FLO）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
FLOWERS FOODS INC的季度营收约是Royalty Pharma plc的2.0倍（$1.2B vs $622.0M），Royalty Pharma plc同比增速更快（4.8% vs -75.8%），过去两年Royalty Pharma plc的营收复合增速更高（4.6% vs -11.6%）
花氏食品总部位于美国佐治亚州托马斯维尔，是美国知名的包装烘焙食品生产商与销售商。公司在全美19个州运营44家面包工厂，生产面包、餐包、小食蛋糕、点心、玉米饼等多元化产品，截至2013年2月已成长为美国第二大烘焙企业。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
FLO vs RPRX — 直观对比
营收规模更大
FLO
是对方的2.0倍
$622.0M
营收增速更快
RPRX
高出80.6%
-75.8%
两年增速更快
RPRX
近两年复合增速
-11.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.2B | $622.0M |
| 净利润 | — | $214.2M |
| 毛利率 | — | — |
| 营业利润率 | — | 62.4% |
| 净利率 | — | 34.4% |
| 营收同比 | -75.8% | 4.8% |
| 净利润同比 | — | 2.9% |
| 每股收益（稀释后） | — | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FLORPRX
| Q4 25 | $1.2B | $622.0M | ||
| Q3 25 | $1.2B | $609.3M | ||
| Q2 25 | $1.6B | $578.7M | ||
| Q1 25 | — | $568.2M | ||
| Q4 24 | $1.2B | $593.6M | ||
| Q3 24 | $1.2B | $564.7M | ||
| Q2 24 | $1.6B | $537.3M | ||
| Q1 24 | — | $568.0M |
净利润FLORPRX
| Q4 25 | $39.5M | $214.2M | ||
| Q3 25 | $58.4M | $288.2M | ||
| Q2 25 | $53.0M | $30.2M | ||
| Q1 25 | — | $238.3M | ||
| Q4 24 | $65.0M | $208.2M | ||
| Q3 24 | $67.0M | $544.0M | ||
| Q2 24 | $73.0M | $102.0M | ||
| Q1 24 | — | $4.8M |
营业利润率FLORPRX
| Q4 25 | 5.4% | 62.4% | ||
| Q3 25 | 7.5% | 70.1% | ||
| Q2 25 | 5.5% | 36.3% | ||
| Q1 25 | — | 94.0% | ||
| Q4 24 | 7.6% | 60.9% | ||
| Q3 24 | 7.8% | — | ||
| Q2 24 | 6.4% | 50.2% | ||
| Q1 24 | — | -13.0% |
净利率FLORPRX
| Q4 25 | 3.2% | 34.4% | ||
| Q3 25 | 4.7% | 47.3% | ||
| Q2 25 | 3.4% | 5.2% | ||
| Q1 25 | — | 41.9% | ||
| Q4 24 | 5.5% | 35.1% | ||
| Q3 24 | 5.5% | 96.3% | ||
| Q2 24 | 4.6% | 19.0% | ||
| Q1 24 | — | 0.8% |
每股收益（稀释后）FLORPRX
| Q4 25 | $0.19 | $0.49 | ||
| Q3 25 | $0.28 | $0.67 | ||
| Q2 25 | $0.25 | $0.07 | ||
| Q1 25 | — | $0.55 | ||
| Q4 24 | $0.31 | $0.46 | ||
| Q3 24 | $0.32 | $1.21 | ||
| Q2 24 | $0.34 | $0.23 | ||
| Q1 24 | — | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $12.1M | $618.7M |
| 总债务越低越好 | — | $9.0B |
| 股东权益账面价值 | — | $9.7B |
| 总资产 | $4.2B | $19.6B |
| 负债/权益比越低杠杆越低 | — | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资FLORPRX
| Q4 25 | $16.7M | $618.7M | ||
| Q3 25 | $11.0M | $938.9M | ||
| Q2 25 | $7.3M | $631.9M | ||
| Q1 25 | — | $1.1B | ||
| Q4 24 | $15.0M | $929.0M | ||
| Q3 24 | $6.9M | $950.1M | ||
| Q2 24 | $15.8M | $1.8B | ||
| Q1 24 | — | $843.0M |
总债务FLORPRX
| Q4 25 | $1.8B | $9.0B | ||
| Q3 25 | $1.7B | $8.9B | ||
| Q2 25 | $1.8B | $8.0B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | $1.1B | $7.6B | ||
| Q3 24 | $1.1B | $7.6B | ||
| Q2 24 | $1.0B | $7.6B | ||
| Q1 24 | — | $6.1B |
股东权益FLORPRX
| Q4 25 | $1.4B | $9.7B | ||
| Q3 25 | $1.4B | $9.6B | ||
| Q2 25 | $1.4B | $9.5B | ||
| Q1 25 | — | $9.8B | ||
| Q4 24 | $1.4B | $10.3B | ||
| Q3 24 | $1.4B | $10.3B | ||
| Q2 24 | $1.4B | $9.8B | ||
| Q1 24 | — | $9.9B |
总资产FLORPRX
| Q4 25 | $4.3B | $19.6B | ||
| Q3 25 | $4.3B | $19.3B | ||
| Q2 25 | $4.3B | $18.3B | ||
| Q1 25 | — | $17.6B | ||
| Q4 24 | $3.4B | $18.2B | ||
| Q3 24 | $3.4B | $18.0B | ||
| Q2 24 | $3.4B | $17.7B | ||
| Q1 24 | — | $16.1B |
负债/权益比FLORPRX
| Q4 25 | 1.25× | 0.92× | ||
| Q3 25 | 1.23× | 0.93× | ||
| Q2 25 | 1.26× | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | 0.75× | 0.74× | ||
| Q3 24 | 0.77× | 0.74× | ||
| Q2 24 | 0.76× | 0.78× | ||
| Q1 24 | — | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $125.4M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 3.86× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流FLORPRX
| Q4 25 | $54.4M | $827.1M | ||
| Q3 25 | $130.8M | $702.6M | ||
| Q2 25 | $135.6M | $364.0M | ||
| Q1 25 | — | $596.1M | ||
| Q4 24 | $113.9M | $742.5M | ||
| Q3 24 | $63.3M | $703.6M | ||
| Q2 24 | $105.1M | $658.2M | ||
| Q1 24 | — | $664.6M |
自由现金流FLORPRX
| Q4 25 | $30.4M | — | ||
| Q3 25 | $100.0M | — | ||
| Q2 25 | $110.1M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $88.6M | — | ||
| Q3 24 | $35.4M | — | ||
| Q2 24 | $71.8M | — | ||
| Q1 24 | — | — |
自由现金流率FLORPRX
| Q4 25 | 2.5% | — | ||
| Q3 25 | 8.0% | — | ||
| Q2 25 | 7.1% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 7.4% | — | ||
| Q3 24 | 2.9% | — | ||
| Q2 24 | 4.6% | — | ||
| Q1 24 | — | — |
资本支出强度FLORPRX
| Q4 25 | 2.0% | — | ||
| Q3 25 | 2.5% | — | ||
| Q2 25 | 1.6% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 2.1% | — | ||
| Q3 24 | 2.3% | — | ||
| Q2 24 | 2.1% | — | ||
| Q1 24 | — | — |
现金转化率FLORPRX
| Q4 25 | 1.38× | 3.86× | ||
| Q3 25 | 2.24× | 2.44× | ||
| Q2 25 | 2.56× | 12.06× | ||
| Q1 25 | — | 2.50× | ||
| Q4 24 | 1.75× | 3.57× | ||
| Q3 24 | 0.94× | 1.29× | ||
| Q2 24 | 1.44× | 6.45× | ||
| Q1 24 | — | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FLO
暂无分部数据
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
